Cargando…
Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma
BACKGROUND: Gastroesophageal adenocarcinoma (GOA) has poor clinical outcomes and lacks reliable blood markers. Here we present circulating tumour DNA (ctDNA) as an emerging biomarker. METHODS: Forty patients (17 palliative and 23 curative) were followed by serial plasma monitoring. Primary tumour DN...
Autores principales: | Openshaw, Mark R., Suwaidan, Ali Abdulnabi, Ottolini, Barbara, Fernandez-Garcia, Daniel, Richards, Cathy J., Page, Karen, Guttery, David S., Thomas, Anne L., Shaw, Jacqui A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555811/ https://www.ncbi.nlm.nih.gov/pubmed/32719550 http://dx.doi.org/10.1038/s41416-020-1002-8 |
Ejemplares similares
-
Optimising Multimodality Treatment of Resectable Oesophago-Gastric Adenocarcinoma
por: Suwaidan, Ali Abdulnabi, et al.
Publicado: (2022) -
RF19 | PSUN353 Liquid Biopsies - Detecting and Tracking Circulating Cell Free Tumor Derived DNA in Patients with Neuroendocrine Neoplasms
por: Gohil, Shailesh, et al.
Publicado: (2022) -
Heterogeneity and evolution of tumour immune microenvironment in metastatic gastroesophageal adenocarcinoma
por: Wang, Wei, et al.
Publicado: (2022) -
Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer
por: Adamo, Patricia, et al.
Publicado: (2017) -
Longitudinal Monitoring of Plasma Circulating Tumour DNA Enables the Prediction of Early Relapse in Patients with Non-Hodgkin Lymphoma: A Case Series
por: Ji, Hongyan, et al.
Publicado: (2021)